Starting from the fundamentals acquired in the Bachelor degree, the Master course addresses the latest and advanced topics and techniques, teaching technologies such as deep sequencing , proteomics , genomics , nanotechnologies , cancer immunology , stem cells for tissue repairing , molecular pathology , developmental neurobiology , organ biochemistry and diagnostic technologies. Paolo Malatesta Head of Programme. Aulaweb Online services.
Specializing to compete: loans from Regione Liguria Read more. News and events. Read all. Find out if you are entitled to scholarships and exemptions International partnerships Student exchange Head of programme Paolo Malatesta. Degree programme.
- Traditional pharmaceutical.
- A brief look at the legacy and future of the United States Navy’s carrier-based support aircraft.
- MATLAB Graphical Programming.
- Morse Theoretic Aspects of p-Laplacian Type Operators (Mathematical Surveys and Monographs).
- The P2 Nucleotide Receptors.
- The Martians Daughter: A Memoir.
- Introduction to Pharmaceutical Biotechnology, Volume 1 - Book - IOPscience!
Dear Students, the Master degree course in Medical-pharmaceutical biotechnology is designed to provide a quality leap in your education. Pharmaceutical Biotechnology offers students taking Pharmacy and related Medical and Pharmaceutical courses a comprehensive introduction to the fast-moving area of biopharmaceuticals. With a particular focus on the subject taken from a pharmaceutical perspective, initial chapters offer a broad introduction to protein science and recombinant DNA technology- key areas that underpin the whole subject. Subsequent chapters focus upon the development, production and analysis of these substances.
Finally the book moves on to explore the science, biotechnology and medical applications of specific biotech products categories. These include not only protein-based substances but also nucleic acid and cell-based products. In conclusion, all the above studies cooperatively reinforce the multidimensional advancements of Food Science that significantly promote human public health and quality of life. Preeclampsia, a unique human pregnancy disorder, is a major cause of maternal and fetal mortality and morbidity worldwide.
It remains amongst the biggest challenges in obstetrics, but its precise aetiopathogenesis is still unclear. Although the main symptom is hypertension, preeclamptic woman manifests the change in many organs. PE is characterized by an increased vascular resistance, increased activation of the coagulation system, and reduction of intravascular volume, injury of vascular endothelium, leading to a reduced perfusion of all maternal organs, including the uterus, kidney, brain and placenta.
Severe cases may include eclamptic seizures, placental abruption, premature labour, intracranial haemorrhage, DIC, HELLP syndrome, renal and hepatic failure.
Severe preeclampsia is always a life threatening human pregnancy complication. Preeclampsia affects not only the mother but also fetus. Currently, no definitive treatment or effective prophylaxis for preeclampsia are available. Delivery still remains the only curative treatment in cases of severe preeclampsia, but is not always advantageous for the fetus.
Muhammad Imran Qadir
The decision is always very difficult because preterm birth may result in many health consequences for the child. The aim of this special issue is exploration of aetiopathogenesis of preeclampsia as well as best practices update and current clinical management of severe preeclampsia, eclampsia and HELLP syndrome. The understanding the etiological determinants of preeclampsia may lead to new therapeutic approaches and is essential for effective therapies and lowering maternal and fetal mortality and morbidity related to these serious pregnancy complications.
Along with the increasing prevalence of cardiovascular and immunological disorders, in a continuously- ageing population, our understanding of the precise mechanisms that regulate cellular complex biochemical environments is increasing. Cellular networks, pathways and biochemical codes are being deciphered, shedding lights on novel therapeutic routes. In this context, inflammation and dysregulated immune system represent a true cellular model that links the pathophysiology of cardiovascular disease and the fine tuning of all the mechanisms that orchestrate the cellular systems.
This Special Issue is composed of important contributions on the topic. The first manuscript addresses an important immunological disease, such as Common variable immunodeficiency CVID , the most frequent symptomatic antibody deficiency in adults, in which the humoral immune impairment exposes patients to a wide spectrum of clinical manifestation, including recurrent infections.
Interestingly, patients with CVID can present with inflammatory, autoimmune disease, hematologic disease and cancers. Varricchi and collaborators  present interesting results from 58 patients diagnosed with CVID and treated with regular immunoglobulin replacement therapy who underwent gastrointestinal endoscopic examination for the evaluation of gastroduodenal manifestations of their CVID.
Histopathologic findings revealed a high prevalence of chronic inflammatory gastrointestinal disorders chronic gastritis, chronic duodenitis, increasing intraepitelial lymphocytes, and the absence of plasma cells that are not responsive to the immunoglobulin replacement therapy. This observation points out that in CVID patients there is a more complex immune dysregulation rather than a true humoral immunity deficiency.
Indeed, these patients could represent a real in vivo model to deeply study immune system activation, autoimmunity and inflammation. In this context, in the second article, dr Pecoraro and colleagues  explored the ability of a simple screening test, the Calculated Gobulin CG , to be effective in the early detection of antibody deficiency, in order to reduce diagnostic delays as well as the healthcare costs of specific immunoglobulin dosage.
Inflammation plays a major role also in the manuscript authored by Pasqua and coworkers , that addresses mechanisms of hypertension, the most prevalent cardiovascular disorder. Here, the authors describe in details the role of NLRP nucleotide binding oligomerization domain Leucine-rich repeat in the pathophysiology of arterial hypertension.
In the context of the danger-model of hypertension, priming hypertensive stimuli could promote the activation of the NLRP3-inflammosome that maintains a low-grade of sterile inflammation in a vicious circle that sustains hypertension itself, thus leading to organ damages. Despite the role of Chemokines in inflammation has been extensively underscored, Sara Paccosi and Astrid Parenti  dissect the role of chemokine pathways in modulating vascular growth mechanisms.
In particular, the family of CC-Chemokines directly interacts with vascular cells, endothelial cells, vascular smooth muscular cells VSMC , fibroblasts, platelets, erythrocytes, and glomerular renal cells in a leukocyte independent-way, being involved in compensatory vascular remodeling such as angiogenesis, atherosclerosis, arteriogenesis. The authors focused on Atypical Chemokine Receptors Families ACKRs , chemokine receptors that were found to have an important scavenger function in regulating chemokine trafficking, and could be considered an interesting potential therapeutic target.
Finally, two complementary and extensive reviews point out the crucial role of the endothelial progenitor cells EPCs , a subunit of mononuclear cells MNCs , in the angiogenesis and remodeling processes, with a special focus as potential therapeutic targets. Guerra and collaborators  investigate the precise role of the circulating EPCs in the remodeling mechanism involved in pulmonary vascular diseases. Pulmonary arterial hypertension PAH is characterized by circulating progenitor recruitment, enhanced angiogenesis and endothelial cell dysfunction that lead to increasing vascular resistances.
Manipulating the VEGF vascular endotelial grow factor signaling pathway to stimulate endothelial vascular growth seems to be a promising venate the angiogenic activity. In conclusion, all the manuscripts of this Special Issue offer different views of the complex mechanisms that regulate inflammation and cardiovascular diseases, from basic science to clinical works, focusing on the special approach that regenerative medicine and genetic manipulation have opened.
These observations should open new routes in the knowledge of different conditions and new promising therapeutic targets. Nowadays, ncRNAs are recognized to be important transcriptional modulators not only capable of suppressing but also of promoting gene expression. Recent research into RNAa has started to unravel the underlying basis linked to saRNA-based activation phenomena and enabled the design of saRNAs with ability to regulate the expression of target genes in different cells types , even being in the process of developing a RNAa therapy against hepatocellular carcinoma [14,15].
Excipient Development for Pharmaceutical, Biotechnology, and Drug Delivery Systems - CRC Press Book
In this thematic issue, Drs. This work is an analytical overview that focuses on the potential that RNAa have for the development of therapeutic strategies. Moreover, canonical and non-canonical mechanisms involving saRNA-mediated gene activation phenomena are also illustrated here. In the next article, Setten et al. In this work, the authors considered the reasons for which MTL-CEBPA represents a promising saRNA drug against hepatocellular carcinoma, thereby opening the door to the development of new therapeutic agents in the treatment of patients with cancer and other diseases.
Finally, Drs. Li and Hu  reviewed the state of the research in the RNAa field and underlie the potential of saRNAs to act as gene modulators, with special emphasis on their use in the treatment of kidney diseases.
UniGe helps you find an accomodation
In this article, the authors associated short ncRNA-mediated gene regulation pathways i. We here introduce the second part of a thematic issue devoted to the analytical advances in clinical and forensic toxicology, with a particular focus on the determination of new psychoactive substances and eventual metabolites in conventional and nonconventional biological matrices . This second part opens with a review which explores the close connections between clinical and forensic toxicology in overlapping areas of interest, such as prenatal exposure to drugs or fetal alcohol syndrome, doping control, sudden cardiac death, determination of brain death, sudden infant death syndrome, Munchausen syndrome by proxy, drug-facilitated crimes and intoxications by new psychoactive substances.
Some of these topics are initially treated in hospital emergency departments, involving clinical laboratories and sometimes lately derived to forensic laboratories. Conversely, cases with initial medicallegal implications and fatalities are directly handled by forensic toxicology, but may trigger further studies in the clinical setting.
Thus, increasing relationships are improving the growth, reliability and robustness of both kind of laboratories, respecting in both cases most recent updated and standard practices for the development and validation of the analytical methods . The first example of the bridges between clinical and forensic toxicology laboratories is given by the case report described by Jarque et al.
The toxicological findings prompted the removal of guardianship to the parents and authorized a temporary foster care. In addition, authors reviewed the updated literature regarding this new outbreak of methamphetamine abuse with several consequences in young male and male adults . An amount of 1. Another interesting issue in clinical and forensic toxicology is that of ethyl glucuronide in hair hEtG used as a biomarker in the diagnosis of chronic excessive alcohol consumption.
Since some cosmetic treatments may influence the hEtG concentration leading to false positive results, the effect of alcohol-based perfumes was studied in four different subjects. The liquid chromatographic mass spectrometric analysis showed in all the cases that prolonged exposition of hair to alcohol-based perfumes may increase hEtG levels, resulting in false positive results . Analytical advances were also reported in a remarkable study concerning a striking problem in doping control: the detection of autologous blood transfusion.
The article of Donati et al. The parameters more strongly affected by the ex vivo storage of whole blood resulted to be erythrocytes size and density, annexin V and microparticles, appearing as a very encouraging suggestion towards the development of a direct method for detecting autologous blood transfusion in sport doping . With respect to the determination of new psychoactive substances and eventual metabolites in conventional and nonconventional biological matrices, an essential contribution has been that of Guillou et al.
In the presented report the research group described and discussed the implementation of the workflow mechanism, regarding the harmonisation of procedures to facilitate the monitoring, communication and management of analytical data obtained by extensive analysis of unknown seized material with some recent real examples. The rapid dissemination of the obtained information is at the moment an essential tool for control authorities to facilitate the protection against the health risks posed by potential harmful psychotropic substances .
On the same line of the previous report has been that of the analytical approaches reviewed by Gerace et al. Due to the high potency and the low doses required to produce desired effects, the risk of overdose for these compounds including severe health implications, is quite high.